![Betty Chang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Betty Chang
Corporate Officer/Principal bij SUMMIT THERAPEUTICS INC.
Actieve functies van Betty Chang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SUMMIT THERAPEUTICS INC. | Corporate Officer/Principal | 01-06-2021 | - |
Loopbaan van Betty Chang
Eerdere bekende functies van Betty Chang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Angarus Therapeutics, Inc.
![]() Angarus Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Angarus Therapeutics, Inc. engages in the development of immuno-oncology therapies. It specializes in modulating the tumor microenvironment by activating innate immunity. The company was founded by Ling Yin Li, Chih Ping Liu, and Mark Smith and is headquartered in Sunnyvale, CA. | Operationeel Directeur | 01-01-2018 | 01-01-2019 |
PHARMACYCLICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2009 | 01-01-2018 |
ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2009 | 01-11-2009 |
RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2004 | 01-01-2009 |
MOLECULAR TEMPLATES, INC. | Corporate Officer/Principal | - | - |
Opleiding van Betty Chang
University of California, Davis | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Operationeel
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 1 |
Chief Operating Officer | 1 |
Sectoraal
Health Technology | 6 |
Health Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
SUMMIT THERAPEUTICS INC. | Health Technology |
MOLECULAR TEMPLATES, INC. | Health Technology |
RIGEL PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Pharmacyclics LLC
![]() Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Angarus Therapeutics, Inc.
![]() Angarus Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Angarus Therapeutics, Inc. engages in the development of immuno-oncology therapies. It specializes in modulating the tumor microenvironment by activating innate immunity. The company was founded by Ling Yin Li, Chih Ping Liu, and Mark Smith and is headquartered in Sunnyvale, CA. | Health Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
![]() Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
- Beurs
- Insiders
- Betty Chang
- Ervaring